THE LEADING PHARMACEUTICAL COMPANY IN BOSNIA AND HERZEGOVINA
We are committed to meeting the expectations of our customers, shareholders and employees.
Investors
Bosnalijek d.d. is in the official quotation of the Sarajevo Stock Exchange (www.sase.ba) under ticker symbol BSNLR. We regularly rank among the top 5 most liquid stocks on the SASE and are classified in the SASX - 10 index. In this section of You can find more information on our business operations our web page.

BSNLR (BAM) KM
Average price: BAM
Change:
Best bid price: BAM
Best ask price: BAM
Volume:
Value: BAM
Number of transactions:
News
ANNUAL REGULAR ASSEMBLY
Notice of convening annual regular assembly of Bosnalijek joint stock company
Pursuant to Article 230, paragraph (1) of Company Law (Official Gazette of FB&H, No. 81/15) and Article 48, paragraph (1) and (2) of valid Bosnalijek d.d. Statute (consolidated text No: 2830/2017 of 18.09.2017), and based on the Supervisory Board's Decision on Convening Annual Regular Assembly No: 1614/19 of 29.05.2019, we hereby announce:
In detail
PRESS CENTRE / NEWS
Bosnalijek achieves Record Turnover of 107 million BAM in Foreign Markets
Bosnalijek recorded great business results in 2017, further underlining its reputation as the leading pharmaceutical company in Bosnia and Herzegovina (BiH). This is confirmed by achieved sales revenue to the amount of 153 million BAM, which represents an increase of 17 million BAM or 13 per cent in comparison to 2016. Profit before tax was 13 million BAM, an increase of 12 per cent compared to profit generated in 2016.
In detail
ANNUAL GENERAL ASSEMBLY/NOTICE
Annual General Assembly of Bosnalijek d.d.
Annual Regular Assembly of Bosnalijek D.D. Sarajevo will be held on 27 June 2019 at 10:00 hours at the Company's premises in Sarajevo, No. 53 Jukićeva St.
MORE
juni 19. 2019 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%